16
Participants
Start Date
June 30, 2015
Primary Completion Date
September 30, 2016
MST-188
Intravenous administration as 100 mg/kg for 1 hour followed by 30 mg/kg/hour for up to 48 hours.
Joe Dimaggio Children's Hospital, Hollywood
Children's Hospital of Southwest Florida, Fort Myers
Our Lady of the Lake Children's Hospital, Baton Rouge
Rady Children's Hospital, San Diego
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
University of Iowa Children's Hospital, Iowa City
Rutgers University, New Brunswick
Medical University of South Carolina, Charleston
T. C. Thompson Children's Hospital, Chattanooga
Lead Sponsor
Mast Therapeutics, Inc.
INDUSTRY